SIS SHULOV INNOVATIVE SCIENCE
Shulov Innovative Science is a biopharmaceutical company focusing on the development of new chemical entities. It specializes in therapeutics uses in dermatology such as anti-viral, anti-inflammatory, and analgesic agents. The company was founded in 1985 and is headquartered in HaMerkaz, Israel.
SIS SHULOV INNOVATIVE SCIENCE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1985-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.sis-shulov.com
Status:
Active
Contact:
+972 8 9314114
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Google Apps For Business Google Maps
Similar Organizations
Kanzawa Medical Research Foundation
Kanzawa Medical Research Foundation promotes the development of healthcare and medical science by encouraging studies.
Sino Biopharmaceutical
Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.sis-shulov.com Semrush global rank: 5.43 M Semrush visits lastest month: 1.56 K
- Host name: 197.183.214.35.bc.googleusercontent.com
- IP address: 35.214.183.197
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "SIS Shulov Innovative Science"
About Us โ S.I.S Shulov
Currently, Shulov innovative Science (SIS) is an advanced clinical-stage biopharmaceutical company focusing on developing New Chemical Entities (NCEโs) for a variety of therapeutic โฆSee details»
Management - S.I.S Shulov
SIS has a highly experienced, diverse and knowledgeable management team. The core management is complemented by some of the best advisors and consultants in the field of โฆSee details»
SIS Shulov Innovative Science - Crunchbase
Contact Email [email protected] Phone Number +972 8 9314114 Shulov Innovative Science is a biopharmaceutical company focusing on the development of new chemical entities.See details»
SIS - Shulov Innovative Science - Overview, News ... - ZoomInfo
View SIS - Shulov Innovative Science org chart to access information on key employees and get valuable insights about SIS - Shulov Innovative Science organizational structure. The โฆSee details»
S.I.S. Shulov Innovative Science Ltd. - Drug pipelines, Patents ...
Apr 2, 2024 Explore S.I.S. Shulov Innovative Science Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Disease Domain:Immune System Diseases ...See details»
S.I.S. SHULOV INNOVATIVE SCIENCE LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for S.I.S. SHULOV INNOVATIVE SCIENCE LTD of REHOVOT, Shfella Area. Get the latest business โฆSee details»
Shulov Innovative Science - VentureRadar
Shulov Innovative Science is an advanced clinical stage biopharmaceutical company focused on the development and commercialization of New Chemical Entities (NCEโs) for topical drug โฆSee details»
SIS Shulov Innovative Science - Crunchbase
Shulov Innovative Science is a biopharmaceutical company focusing on the development of new chemical entities. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โฆSee details»
SIS Shulov Innovative Science - Novel Pharmaceutical Entities for ...
Shulov Institute for Science (SIS) is an advanced clinical-stage biopharmaceutical company focusing on the development, manufacturing, and testing of novel... Log in Sign up. โฆSee details»
SIS Shulov Innovative Science Overview - Start-Up Nation Central
Mar 28, 2006 Shulov Innovative Science (SIS) is an advanced clinical-stage biopharmaceutical company focusing on developing New Chemical Entities (NCEโs) for a variety of therapeutic โฆSee details»
Innovation - S.I.S Shulov
SIS Innovation . A novel, non-toxic, the short peptide has been isolated from snake venom based on its highly potent in-vivo analgesic activity upon topical application. ... Shulov Innovative โฆSee details»
Lung Inflammation (SIS) - Drug Targets, Indications, Patents
Lung Inflammation(SIS), Initially developed by S.I.S. Shulov Innovative Science Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Infectious ...See details»
SIS Shulov Innovative Science - Contacts, Employees, Board โฆ
SIS Shulov Innovative Science has 1 current employee profile, CEO Aviv Marx. Contacts. Edit Contacts Section. We're working on getting contact data for SIS Shulov Innovative Science . โฆSee details»
Burns(SIS) - Drug Targets, Indications, Patents - Synapse - Patsnap
Burns(SIS), Initially developed by S.I.S. Shulov Innovative Science Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Other Diseases, Active ...See details»
Contact โ S.I.S Shulov
© 2018 Shulov Institute for Science LTD. Brand and Design โ Talking Brand LtdTalking Brand LtdSee details»
S.I.S. Shulov Innovative Science Ltd. (S.I.S. Shulov Innovative โฆ
ไบ่งฃS.I.S. Shulov Innovative Science Ltd. (S.I.S. Shulov Innovative Science Ltd.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็3้กนไธดๅบ่ฏ้ช, 1็ฏๆฐ้ป๏ผ็พ็ ้ขๅ:ๆๆ๏ผๅ ็ซ็ณป็ป็พ็ ๏ผ็ฅ โฆSee details»
ZEP 3 - AdisInsight - Springer
Aug 8, 2022 04 Jun 2019 SIS Shulov Innovative Science intends to schedule a pre-IND meeting with the US FDA in Q1 2019 to initiate phase-III trial in Herpes labialis in USA (SIS Shulov โฆSee details»
Pipeline - S.I.S Shulov
SIS is an advanced clinical-stage biopharmaceutical company focusing on developing New Chemical Entities (NCEโs) with a unique combination of anti-inflammatory, anti-viral, and โฆSee details»
Clinical Studies - S.I.S Shulov
SIS has conducted a large variety of pre-clinical studies according to the requirements of the health regulatory authorities, all to support the pharmaceutical development of ZEP-3 and ZEP โฆSee details»